RECORDIINCT07739316
Systematic Ambulatory ECG Monitoring Following TAVI
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Recruitment opened Show 4 more changesShow less
- Eligibility criteria expanded, about 8 words
- Start date changed from estimate of Aug 2026 to Oct 23, 2026
- Site details revised
- Publications: details revised at 28 of 28 entries
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (21)
Show 16 moreShow less
Arms and interventions
Participants will undergo ambulatory ECG monitoring at hospital discharge following TAVI. Continuous ECG monitoring will be performed for 14 days using an ambulatory ECG monitoring device. Clinically significant bradyarrhythmias or tachyarrhythmias detected during monitoring will be reviewed and managed according to clinical practice, including appropriate therapeutic interventions when indicated.
Participants will receive standard post-TAVI care without systematic ambulatory ECG monitoring at hospital discharge. Clinical follow-up will be performed according to routine practice.
Devices: Ambulatory ECG monitoring
Sites
1 site in 1 country
- Institut universitaire de cardiologie et de pneumologie de Québec - ULQuébec, Quebec, Canada